252 related articles for article (PubMed ID: 31097685)
1. c-FLIP and CD95 signaling are essential for survival of renal cell carcinoma.
Luebke T; Schwarz L; Beer YY; Schumann S; Misterek M; Sander FE; Plaza-Sirvent C; Schmitz I
Cell Death Dis; 2019 May; 10(6):384. PubMed ID: 31097685
[TBL] [Abstract][Full Text] [Related]
2. c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis.
Mathas S; Lietz A; Anagnostopoulos I; Hummel F; Wiesner B; Janz M; Jundt F; Hirsch B; Jöhrens-Leder K; Vornlocher HP; Bommert K; Stein H; Dörken B
J Exp Med; 2004 Apr; 199(8):1041-52. PubMed ID: 15078899
[TBL] [Abstract][Full Text] [Related]
3. Resistance of cutaneous anaplastic large-cell lymphoma cells to apoptosis by death ligands is enhanced by CD30-mediated overexpression of c-FLIP.
Braun FK; Hirsch B; Al-Yacoub N; Dürkop H; Assaf C; Kadin ME; Sterry W; Eberle J
J Invest Dermatol; 2010 Mar; 130(3):826-40. PubMed ID: 19890350
[TBL] [Abstract][Full Text] [Related]
4. Cordycepin promotes apoptosis in renal carcinoma cells by activating the MKK7-JNK signaling pathway through inhibition of c-FLIPL expression.
Hwang IH; Oh SY; Jang HJ; Jo E; Joo JC; Lee KB; Yoo HS; Lee MY; Park SJ; Jang IS
PLoS One; 2017; 12(10):e0186489. PubMed ID: 29045468
[TBL] [Abstract][Full Text] [Related]
5. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes.
Moriyama H; Yonehara S
Immunol Lett; 2007 Mar; 109(1):36-46. PubMed ID: 17275920
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis in 9-nitrocamptothecin-treated DU145 human prostate carcinoma cells correlates with de novo synthesis of CD95 and CD95 ligand and down-regulation of c-FLIP(short).
Chatterjee D; Schmitz I; Krueger A; Yeung K; Kirchhoff S; Krammer PH; Peter ME; Wyche JH; Pantazis P
Cancer Res; 2001 Oct; 61(19):7148-54. PubMed ID: 11585748
[TBL] [Abstract][Full Text] [Related]
7. Delineating the role of c-FLIP/NEMO interaction in the CD95 network via rational design of molecular probes.
Ivanisenko NV; Buchbinder JH; Espe J; Richter M; Bollmann M; Hillert LK; Ivanisenko VA; Lavrik IN
BMC Genomics; 2019 May; 20(Suppl 3):293. PubMed ID: 31815628
[TBL] [Abstract][Full Text] [Related]
8. Human T-cell leukemia virus type-I oncoprotein Tax inhibits Fas-mediated apoptosis by inducing cellular FLIP through activation of NF-kappaB.
Okamoto K; Fujisawa J; Reth M; Yonehara S
Genes Cells; 2006 Feb; 11(2):177-91. PubMed ID: 16436054
[TBL] [Abstract][Full Text] [Related]
9. Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex.
Kavuri SM; Geserick P; Berg D; Dimitrova DP; Feoktistova M; Siegmund D; Gollnick H; Neumann M; Wajant H; Leverkus M
J Biol Chem; 2011 May; 286(19):16631-46. PubMed ID: 21454681
[TBL] [Abstract][Full Text] [Related]
10. Identification of c-FLIP(L) and c-FLIP(S) as critical regulators of death receptor-induced apoptosis in pancreatic cancer cells.
Haag C; Stadel D; Zhou S; Bachem MG; Möller P; Debatin KM; Fulda S
Gut; 2011 Feb; 60(2):225-37. PubMed ID: 20876774
[TBL] [Abstract][Full Text] [Related]
11. The relevance of NF-kappaB for CD95 signaling in tumor cells.
Legembre P; Barnhart BC; Peter ME
Cell Cycle; 2004 Oct; 3(10):1235-9. PubMed ID: 15467462
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of c-FLIP short by NFAT contributes to apoptosis resistance of short-term activated T cells.
Ueffing N; Schuster M; Keil E; Schulze-Osthoff K; Schmitz I
Blood; 2008 Aug; 112(3):690-8. PubMed ID: 18509086
[TBL] [Abstract][Full Text] [Related]
13. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways.
Kataoka T; Budd RC; Holler N; Thome M; Martinon F; Irmler M; Burns K; Hahne M; Kennedy N; Kovacsovics M; Tschopp J
Curr Biol; 2000 Jun; 10(11):640-8. PubMed ID: 10837247
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant c-FLIP inhibits Fas ligand-induced NF-kappaB activation in a phosphatidylinositol 3-kinase/Akt-dependent manner.
Iyer AK; Azad N; Talbot S; Stehlik C; Lu B; Wang L; Rojanasakul Y
J Immunol; 2011 Sep; 187(6):3256-66. PubMed ID: 21856935
[TBL] [Abstract][Full Text] [Related]
15. Caspase-10 Negatively Regulates Caspase-8-Mediated Cell Death, Switching the Response to CD95L in Favor of NF-κB Activation and Cell Survival.
Horn S; Hughes MA; Schilling R; Sticht C; Tenev T; Ploesser M; Meier P; Sprick MR; MacFarlane M; Leverkus M
Cell Rep; 2017 Apr; 19(4):785-797. PubMed ID: 28445729
[TBL] [Abstract][Full Text] [Related]
16. In mouse embryonic fibroblasts, neither caspase-8 nor cellular FLICE-inhibitory protein (FLIP) is necessary for TNF to activate NF-κB, but caspase-8 is required for TNF to cause cell death, and induction of FLIP by NF-κB is required to prevent it.
Moujalled DM; Cook WD; Lluis JM; Khan NR; Ahmed AU; Callus BA; Vaux DL
Cell Death Differ; 2012 May; 19(5):808-15. PubMed ID: 22095280
[TBL] [Abstract][Full Text] [Related]
17. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
18. Regulation of extrinsic apoptotic signaling by c-FLIP: towards targeting cancer networks.
Ivanisenko NV; Seyrek K; Hillert-Richter LK; König C; Espe J; Bose K; Lavrik IN
Trends Cancer; 2022 Mar; 8(3):190-209. PubMed ID: 34973957
[TBL] [Abstract][Full Text] [Related]
19. Dynamics within the CD95 death-inducing signaling complex decide life and death of cells.
Neumann L; Pforr C; Beaudouin J; Pappa A; Fricker N; Krammer PH; Lavrik IN; Eils R
Mol Syst Biol; 2010; 6():352. PubMed ID: 20212524
[TBL] [Abstract][Full Text] [Related]
20. Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells.
Song JH; Tse MC; Bellail A; Phuphanich S; Khuri F; Kneteman NM; Hao C
Cancer Res; 2007 Jul; 67(14):6946-55. PubMed ID: 17638906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
